Relmada Therapeutics, Inc. (RLMD)
NASDAQ·Healthcare·Biotechnology
$7.10
+0.85%
Mkt Cap $528.74M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (6 analysts)
$9.00
Range $8.00 – $10.00
Implied Upside
+26.8%
Consensus $9.00 vs current $7.10
NASDAQ·Healthcare·Biotechnology
$7.10
+0.85%
Mkt Cap $528.74M
Buy
3
Hold
0
Sell
0
Price Target (6 analysts)
$9.00
Range $8.00 – $10.00
+26.8%
Consensus $9.00 vs current $7.10